Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even with statin therapy for dyslipidemia, individuals with EOT2D continue to exhibit a significant burden of atherogenic apolipoprotein particles compared to those with later-onset T2DM, though the long-term consequences remain unknown [52].”
From Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions (2025) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492
Heart Protection Study Collaborative Group (2011) · The Lancet · doi:10.1016/s0140-6736(11)61125-2 · Cited by 373
Marcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342
Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., & Sattar, N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.2 · Cited by 281
Elkeles, R. S., Godsland, I. F., Feher, M. D., Rubens, M. B., Roughton, M., Nugara, F., Humphries, S. E., Richmond, W., Flather, M. D., & for the PREDICT Study Group (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn279 · Cited by 261 · cited 1×
“of cardiovascular disease in diabetes.(19) In earlyonset T2D, however, relatively few studies have investigated the contributory role of these atherogenic particles to the cardiovascular risk, the study populations being statin-naı̈ve subjects.”
BackgroundMarcovina, S. M., Albers, J. J., Kennedy, H., Mei, J. V., Henderson, L. O., & Hannon, W. H. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.586 · Cited by 243
O’Gorman, D. J., Karlsson, H. K. R., McQuaid, S., Yousif, O., Rahman, Y., Gasparro, D., Glund, S., Chibalin, A. V., Zierath, J. R., & Nolan, J. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0457-3 · Cited by 226
Faergeman, O., Holme, I., Fayyad, R., Bhatia, S., Grundy, S. M., Kastelein, J. J. P., LaRosa, J. C., Larsen, M. L., Lindahl, C., Olsson, A. G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.008 · Cited by 154
Martin, S. S., Qasim, A. N., Mehta, N. N., Wolfe, M., Terembula, K., Schwartz, S., Iqbal, N., Schutta, M., Bagheri, R., & Reilly, M. P. (2009) · Diabetes · doi:10.2337/db08-1794 · Cited by 60
Research works printed but not linked: 27
- McQuaid, 2005, Diabetes Care, 28, 1216, 10.2337/diacare.28.5.1216 · DOI
- Benhalima, 2011, 5, 245, 10.1016/j.pcd.2011.06.003 · DOI · Paper page
- Hatunic, 2007, Diabetes and Vascular Disease Research, 4, 231, 10.3132/dvdr.2007.045 · DOI
- 2009, Diabetes Care, 32, 175, 10.2337/dc08-1442 · DOI
- 2008, Journal of Clinical Endocrinology & Metabolism, 93, 735, 10.1210/jc.2007-2176 · DOI · Paper page
- Hillier, 2003, Diabetes Care, 26, 2999, 10.2337/diacare.26.11.2999 · DOI · Paper page
- Colhoun, 2004, Lancet, 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
- Kearney, 2008, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X · DOI · Paper page
- Sniderman, 2003, Lancet, 361, 777, 10.1016/S0140-6736(03)12663-3 · DOI · Paper page
- Charlton-Menys, 2009, 52, 218, 10.1007/s00125-008-1176-8 · DOI
- Friedewald, 1972, Clinical Chemistry, 18, 499, 10.1093/clinchem/18.6.499 · DOI · Paper page
- Rubies-Prat, 1993, Diabetes Care, 16, 1081, 10.2337/diacare.16.8.1081 · DOI · Paper page
- 2009, QJM, 102, 799, 10.1093/qjmed/hcp121 · DOI · Paper page
- Young, 2008, The American journal of managed care, 14, 15
- Emanuele, 1998, Archives of Internal Medicine, 158, 2485, 10.1001/archinte.158.22.2485 · DOI
- Sniderman, 2001, Annals of Internal Medicine, 135, 447, 10.1001/archinte.161.3.447 · doi:10.1001/archinte.161.3.447
- 2007, 50, 1500, 10.1007/s00125-007-0655-7 · DOI
- 2002, American Journal of Physiology - Endocrinology And Metabolism, 283, E1135, 10.1152/ajpendo.0327.2001 · DOI · Paper page
- Rhodes, 2012, Diabetic medicine : a journal of the British Diabetic Association, 29, 453, 10.1111/j.1464-5491.2011.03542.x · DOI · Paper page
- 2009, Journal of Clinical Endocrinology & Metabolism, 94, 3740, 10.1210/jc.2008-2039 · DOI · Paper page
- Guzder, 2007, Diabetic medicine : a journal of the British Diabetic Association, 24, 1164, 10.1111/j.1464-5491.2007.02223.x · DOI
- 2008, Diabetes Care, 31, 1761, 10.2337/dc08-0137 · DOI · Paper page
- Gaede, 2003, New England Journal of Medicine, 348, 383, 10.1056/NEJMoa021778 · DOI · Paper page
- Garvey, 2003, Diabetes, 52, 453, 10.2337/diabetes.52.2.453 · DOI · Paper page
- Brunzell, 2008, Diabetes Care, 31, 811, 10.2337/dc08-9018 · DOI · Paper page
- Jones, 2004, Clinical therapeutics, 26, 1388, 10.1016/j.clinthera.2004.09.006 · DOI
- Song, 2008, Expert review of cardiovascular therapy, 6, 315, 10.1586/14779072.6.3.315 · DOI · Paper page
Cited by
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70137-8 · Cited by 296
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0561 · Cited by 11
Metadata
- Authors
- Song, S. H., & Gray, T. A.
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-28
- Volume
- 105
- Issue
- 10
- Pages
- 973-980
- ISSN
- 1460-2725
- 1460-2393
- Cited by
- 8
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment. https://app.cochat.ai/papers/10.1093/qjmed/hcs113
- The paper
- Song, S. H., & Gray, T. A. (2012). Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment. QJM. https://doi.org/10.1093/qjmed/hcs113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.